To further investigate the relationship between SLC2A10 and lung cancer immunity, we used TIMER and GEPIA to explore the correlation between gene expression and immune marker sets of various immune cells of LUAD and LUSC. This evidence concerns the gene SLC2A10 and lung cancer.